newsfilter
← Latest News
GlobeNewswire·

Atreca Reports Fourth Quarter and Full-Year 2021 Financial Results and ATRC-101 Data Update

Partial response (PR) observed in ATRC-101 monotherapy cohort as well as a confirmed complete response (CR) observed in pembrolizumab combination cohort in Phase 1b clinical trial Clinical activity observed in multiple tumor types and significantly